HPV阳性口咽鳞状细胞癌经口机器人手术后辅助质子放疗
回顾性分析47例HPV相关口咽鳞状细胞癌患者,接受经口机器人手术(TORS)后辅助质子束放疗(PBT)。急性毒性以1-2级为主(98.3%),仅1例(2.1%)出现3级毒性;6.4%患者需营养管。常见慢性毒性包括口干、吞咽困难、味觉障碍和淋巴水肿,随时间推移频率似乎下降,但需进一步研究。
要点
- 47例HPV阳性口咽癌患者接受TORS后辅助PBT,急性毒性多为1-2级。
- 仅1例(2.1%)发生3级急性毒性,3例(6.4%)需营养管。
- 慢性毒性包括口干、吞咽困难等,随时间推移似乎减少,但需进一步研究。
核心结论
- HPV相关口咽鳞状细胞癌接受TORS后辅助PBT显示有利的毒性特征,急性毒性大多为1级或2级。
- 辅助PBT期间需营养管的比例较低,为6.4%。
- 许多慢性毒性似乎随放疗后时间推移频率下降,但需进一步研究。
研究设计与样本
- 回顾性综述,纳入2017年至2023年在马里兰州巴尔的摩一家学术三级医疗中心接受TORS后辅助PBT的患者。
- 共47例HPV相关口咽鳞状细胞癌患者。
主要发现
- 41例(87.2%)为男性,首次放疗分割时的中位年龄为61.7岁。
- 41例(87.2%)为白人,6例(12.8%)为非裔美国人。
- 多数患者为T1期(23例[48.9%])或T2期(22例[46.8%]),N1期(41例[87.2%])。
- 98.3%的急性毒性为1级或2级,仅1例(2.1%)患者发生3级毒性。
- 3例(6.4%)患者在辅助质子放疗期间需要营养管;这3例在放疗期间需要营养管者术后也需鼻胃管,中位16天,而其他所有患者为3天(Mann-Whitney U检验,P=0.02)。
局限性
- 原文未报告局限性;但结论指出许多慢性毒性似乎随时间推移频率下降,仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Advances in the treatment of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) include transoral robotic surgery (TORS) and proton beam therapy (PBT). This study aims to improve understanding of the treatment toxicities associated with adjuvant PBT following TORS for OPSCC. STUDY DESIGN: A retrospective review. SETTING: An academic tertiary care center in Baltimore, Maryland. METHODS: Patients undergoing TORS followed by adjuvant PBT from 2017 to 2023 were reviewed. RESULTS: Forty-seven patients with HPV-associated OPSCC underwent TORS followed by adjuvant PBT. Forty-one (87.2%) patients were male. The median age at first radiation fraction was 61.7 years. Forty-one (87.2%) identified as white and 6 (12.8%) as African American. Most patients had T1 (23 [48.9%]) or T2 (22 [46.8%]), N1 (41 [87.2%]) disease. The majority (98.3%) of acute toxicities were grade 1 or 2, with only 1 (2.1%) patient developing grade 3 toxicities. Three (6.4%) patients required a feeding tube for nutrition during adjuvant proton radiation treatment. The 3 patients who required feeding tubes during radiation also required postoperative nasogastric tubes for a median of 16 days, compared with 3 days for all other patients (Mann-Whitney U, P = .02). The most common chronic toxicities included xerostomia, dysphagia, dysgeusia, and lymphedema, which decreased over time. CONCLUSION: HPV-associated OPSCC treated with TORS followed by adjuvant PBT demonstrated a favorable toxicity profile with mostly grade 1 or 2 acute toxicities. Feeding tube requirement during adjuvant PBT was low at 6.4%. Many chronic toxicities appeared to decrease in frequency with time from radiation, although further study is required.
引用
- Tong JY, Bzhilyanskaya V, Ferris MJ, et al. Adjuvant Proton Radiation Following Transoral Robotic Surgery for HPV-Positive Oropharyngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2025. PMID: 39887800. doi:10.1002/ohn.1150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。